@misc{indiciaec8d011e8895d,
  title = {KDM5 inhibition offers a novel therapeutic strategy for the treatment of KMT2D mutant lymphomas},
  author = {Heward, J. A. and Koniali, L. and D'Avola, A. and Close, K. and Yeomans, A. and Philpott, M. and Dunford, J. and Rahim, T. and Al Seraihi, A. F. and Wang, J. and Korfi, K. and Araf, S. and Iqbal, S. and Bewicke-Copley, F. and Kumar, E. and Barisic, D. and Calaminici, M. and Clear, A. and Gribben, J. and Johnson, P. and Neve, R. and Okosun, J. and Oppermann, U. and Melnick, A. and Packham, G. and Fitzgibbon, J.},
  year = {2020},
  doi = {10.1101/2020.06.30.177477},
  url = {https://www.biorxiv.org/content/10.1101/2020.06.30.177477v1},
  note = {Source identifier: 10.1101/2020.06.30.177477}
}